AssetMark Inc’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $41.8K | Hold |
1,495
| – | – | ﹤0.01% | 1896 |
|
|
2026
Q1 | $42.7K | Sell |
1,495
-76
| -5% | -$2.59K | ﹤0.01% | 1805 |
|
|
2025
Q4 | $62.1K | Hold |
1,571
| – | – | ﹤0.01% | 1642 |
|
|
2025
Q3 | $55.4K | Hold |
1,571
| – | – | ﹤0.01% | 1598 |
|
|
2025
Q2 | $51.5K | Buy |
1,571
+185
| +13% | +$6.01K | ﹤0.01% | 1556 |
|
|
2025
Q1 | $44.7K | Hold |
1,386
| – | – | ﹤0.01% | 1465 |
|
|
2024
Q4 | $42.4K | Sell |
1,386
-20
| -1% | -$643 | ﹤0.01% | 1466 |
|
|
2024
Q3 | $39.4K | Sell |
1,406
-27,910
| -95% | -$688K | ﹤0.01% | 1344 |
|
|
2024
Q2 | $668K | Buy |
29,316
+7,963
| +37% | +$184K | ﹤0.01% | 833 |
|
|
2024
Q1 | $650K | Buy |
21,353
+3,856
| +22% | +$129K | ﹤0.01% | 793 |
|
|
2023
Q4 | $624K | Buy |
17,497
+7,451
| +74% | +$277K | ﹤0.01% | 764 |
|
|
2023
Q3 | $440K | Buy |
10,046
+1,537
| +18% | +$75K | ﹤0.01% | 779 |
|
|
2023
Q2 | $420K | Buy |
8,509
+1,665
| +24% | +$76.7K | ﹤0.01% | 756 |
|
|
2023
Q1 | $284K | Buy |
6,844
+865
| +14% | +$35.9K | ﹤0.01% | 785 |
|
|
2022
Q4 | $265K | Buy |
5,979
+1,689
| +39% | +$70.5K | ﹤0.01% | 786 |
|
|
2022
Q3 | $168K | Buy |
4,290
+1,398
| +48% | +$64K | ﹤0.01% | 786 |
|
|
2022
Q2 | $118K | Buy |
2,892
+1,428
| +98% | +$67.6K | ﹤0.01% | 800 |
|
|
2022
Q1 | $96K | Buy |
1,464
+454
| +45% | +$29.4K | ﹤0.01% | 797 |
|
|
2021
Q4 | $70K | Hold |
1,010
| – | – | ﹤0.01% | 845 |
|
|
2021
Q3 | $70K | Hold |
1,010
| – | – | ﹤0.01% | 715 |
|
|
2021
Q2 | $80K | Sell |
1,010
-25
| -2% | -$1.82K | ﹤0.01% | 668 |
|
|
2021
Q1 | $68K | Hold |
1,035
| – | – | ﹤0.01% | 684 |
|
|
2020
Q4 | $58K | Hold |
1,035
| – | – | ﹤0.01% | 687 |
|
|
2020
Q3 | $41K | Hold |
1,035
| – | – | ﹤0.01% | 709 |
|
|
2020
Q2 | $47K | Sell |
1,035
-150
| -13% | -$6.53K | ﹤0.01% | 659 |
|
|
2020
Q1 | $40K | Sell |
1,185
-90
| -7% | -$3.24K | ﹤0.01% | 729 |
|
|
2019
Q4 | $41K | Buy |
1,275
+300
| +31% | +$8.54K | ﹤0.01% | 784 |
|
|
2019
Q3 | $24K | Hold |
975
| – | – | ﹤0.01% | 852 |
|
|
2019
Q2 | $29K | Buy |
975
+510
| +110% | +$14.9K | ﹤0.01% | 815 |
|
|
2019
Q1 | $12K | Hold |
465
| – | – | ﹤0.01% | 959 |
|
|
2018
Q4 | $14K | Buy |
+465
| New | +$14.5K | ﹤0.01% | 943 |
|
Other funds holding ATRC
HRCM
NAMI
AssetMark Inc's ATRC Position: Q2 2026 in Review
AssetMark Inc held its AtriCure (ATRC) position steady in Q2 2026 at 1,495 shares worth $41.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1896.
AssetMark Inc first reported a position in ATRC in Q4 2018 and has held it in 31 quarters since. The position peaked at $668K in Q2 2024. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- AssetMark Inc held 1,495 shares of AtriCure worth $41.8K as of Q2 2026.
- AssetMark Inc left its AtriCure share count unchanged in Q2 2026.
- AtriCure made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1896 holding.
- AssetMark Inc first reported a position in AtriCure in Q4 2018 and has held it in 31 quarters since.
- AssetMark Inc's AtriCure position peaked at $668K in Q2 2024.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.